Based on this downregulation and the finding that Atrx deletion reduced activation of the CGAS/STING response to microbial-derived dsDNA, we investigated whether Atrx deletion increased sensitivity to an oncolytic HSV-1 designed to specifically target and kill tumor cells. The gene discussed is ATRX; the disease is neoplasm.